Rosanna Lau, Ph.D.
Affiliations: | 2012 | Cellular and Molecular Medicine | University of Ottawa, Ottawa, ON, Canada |
Area:
Cell Biology, OncologyGoogle:
"Rosanna Lau"Parents
Sign in to add mentorChristine Pratt | grad student | 2012 | University of Ottawa | |
(cIAP2 negatively regulates proliferation and tumourigenesis by repressing IKK activity and maintaining p53 function.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Echeverria GV, Cai S, Tu Y, et al. (2023) Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer. Npj Breast Cancer. 9: 2 |
Bossuyt V, Lau R, Young B, et al. (2021) Intra- and Interlaboratory Reproducibility of the Sensitivity to Endocrine Therapy Assay for Stage II/III Breast Cancer. Clinical Chemistry |
Fu C, Marczyk M, Samuels M, et al. (2021) Targeted RNAseq assay incorporating unique molecular identifiers for improved quantification of gene expression signatures and transcribed mutation fraction in fixed tumor samples. Bmc Cancer. 21: 114 |
Lau R, Du L, Chen E, et al. (2020) Technical Validity of a Customized Assay of Sensitivity to Endocrine Therapy Using Sections from Fixed Breast Cancer Tissue. Clinical Chemistry |
Cabrita MA, Renart LI, Lau R, et al. (2019) Intrinsically Disordered SRC-3/AIB1 Protein Undergoes Homeostatic Nuclear Extrusion by Nuclear Budding While Ectopic Expression Induces Nucleophagy. Cells. 8 |
Sinn BV, Fu C, Lau R, et al. (2019) SET: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer. Npj Breast Cancer. 5: 16 |
Echeverria GV, Ge Z, Seth S, et al. (2019) Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state. Science Translational Medicine. 11 |
Marczyk M, Fu C, Lau R, et al. (2019) Abstract P4-08-20: Pre-analytical effects of FFPE extraction methods on targeted and whole transcriptome sequencing assays for endocrine sensitivity in metastatic breast cancer Cancer Research |
Seth S, Huo L, Rauch G, et al. (2019) Abstract P3-07-01: Towards a therapeutically relevant subtyping scheme for triple-negative breast cancer (TNBC), profiling results from A Randomized, TNBC Enrolling trial to confirm Molecular profiling Improves Survival (ARTEMIS) Cancer Research. 79 |
Echeverria G, Ge Z, Seth S, et al. (2019) Abstract GS5-05: Resistance to neoadjuvant chemotherapy in triple negative breast cancer mediated by a reversible drug-tolerant state Cancer Research. 79 |